EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma

Richard Huan Xu, Zuyi Zhao, Tianxin Pan, Andrea Monteiro, Hongfei Gu, Dong Dong

The European Journal of Health Economics · 2025-06 · 26 (4) · 671-682

DOI: 10.1007/s10198-024-01730-x ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The European Journal of Health Economics, online erschienen am 17.10.2024. Verfasst von Richard Huan Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: Hodgkin Disease, Quality of Life, Cancer Survivors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the measurement properties of EQ-5D-5 L, SF-6Dv2, QLU-C10D, and FACT-8D in survivors of Classical Hodgkin’s Lymphoma (CHL).

Methods

A cross-sectional, web-based survey was conducted from May to August 2022 to collect data. Chinese value sets were used to estimate the utility scores for EQ-5D-5 L, SF-6Dv2, and QLU-C10D, while the Australian value set was used for FACT-8D. The measurement properties assessed included ceiling and floor effects, convergent validity (assessing associations between similar dimensions/utility scores using Spearman’s rank correlation and intraclass correlation coefficient), and known-group validity (measures could differentiate health-related quality of life (HRQoL) between risk groups).

Results

A total of 534 CHL survivors participated in the survey and completed the questionnaire. All dimensions of EQ-5D-5 L, SF-6D (except for vitality), QLU-C10D, and FACT-8D showed ceiling effects, ranging from 18 to 91.6%. The EQ-5D-5 L demonstrated the higher ceiling effects compared to other measures, with 33% of patients reporting full health on this scale. All 30 pairs of associations between similar dimensions from the four measures were statistically significant, with correlation coefficients ranging from 0.29 to 0.77. Regarding utility scores, the EQ-5D-5 L utility score showed a stronger correlation with SF-6Dv2 than with the other two measures. Statistically significant correlations of utility scores between the four measures were observed. EQ-5D-5 L can significantly differentiate HRQoL among all known-groups, while SF-6Dv2, QLU-C10D, and FACT-8D showed a less strong discriminant ability.

Conclusions

EQ-5D-5 L outperformed SF-6Dv2 in terms of agreement with cancer-specific PRMs and discriminant ability. However, SF-6Dv2 showed stronger associations with similar dimensions of QLU-C10D and FACT-8D, indicating high convergent validity. The generic PBMs are sensitive enough to measure HRQoL in survivors of CHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseQuality of LifeCancer SurvivorsHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedSurveys and QuestionnairesReproducibility of ResultsAgedAustraliaChinaPsychometricsYoung AdultHealth StatusAdolescent

Stichwörter der Autor:innen

EQ-5DFACT-8DLymphomaMeasurement propertiesOncologyPreference-based measureQLU-C10DSF-6D

Autor:innen und Institutionen

  • Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong, China.
  • Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, USA.
  • Hongmian Cancers and Rare Disorders Charity Foundation of Guangzhou, Guangzhou, China.
  • JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. dongdong@cuhk.edu.hk.

Zitieren

APA

Xu, R. H., Zhao, Z., Pan, T., Monteiro, A., Gu, H., & Dong, D. (2025). Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma. The European Journal of Health Economics, 26(4), 671-682. https://doi.org/10.1007/s10198-024-01730-x

Vancouver

Xu RH, Zhao Z, Pan T, Monteiro A, Gu H, Dong D. Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma. The European Journal of Health Economics. 2025;26(4):671-682. doi:10.1007/s10198-024-01730-x

BibTeX
@article{Xu2025,
  author = {Xu, Richard Huan and Zhao, Zuyi and Pan, Tianxin and Monteiro, Andrea and Gu, Hongfei and Dong, Dong},
  title = {Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma},
  journal = {The European Journal of Health Economics},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {671--682},
  doi = {10.1007/s10198-024-01730-x}
}
Kostenlos starten →